Accessibility Menu

In the following video, Motley Fool health care bureau chief Brenton Flynn discusses a recent Bloomberg article, which highlights the incredible benefits pharmaceutical companies enjoy through tax management strategies. Brenton tells investors who is profiting and by how much, and why other large-cap health care companies like UnitedHealth Group (UNH +0.64%) and Express Scripts (ESRX +0.00%) are missing out.

Read Next

Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends Express Scripts, Johnson & Johnson, and UnitedHealth Group. The Motley Fool owns shares of Express Scripts and Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Stocks Mentioned

Merck Stock Quote
Merck
NYSE: MRK
$127.51
(-0.09%)-$0.12
Stock Advisor

Motley Fool Stock Advisor’s Latest Pick

Get Access
---% Avg Return
Johnson & Johnson Stock Quote
Johnson & Johnson
NYSE: JNJ
$253.04
(+1.23%)+$3.07
Abbott Laboratories Stock Quote
Abbott Laboratories
NYSE: ABT
$100.70
(+1.89%)+$1.87
UnitedHealth Group Stock Quote
UnitedHealth Group
NYSE: UNH
$426.09
(+0.64%)+$2.71

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services